Annual Working Capital
$8.78 M
-$363.30 K-3.97%
December 1, 2023
Summary
- As of February 7, 2025, BRTX annual working capital is $8.78 million, with the most recent change of -$363.30 thousand (-3.97%) on December 1, 2023.
- During the last 3 years, BRTX annual working capital has risen by +$6.64 million (+310.01%).
- BRTX annual working capital is now -58.38% below its all-time high of $21.10 million, reached on December 31, 2021.
Performance
BRTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$8.93 M
-$756.50 K-7.81%
September 1, 2024
Summary
- As of February 7, 2025, BRTX quarterly working capital is $8.93 million, with the most recent change of -$756.50 thousand (-7.81%) on September 1, 2024.
- Over the past year, BRTX quarterly working capital has dropped by -$2.74 million (-23.51%).
- BRTX quarterly working capital is now -57.70% below its all-time high of $21.10 million, reached on December 31, 2021.
Performance
BRTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
BRTX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.0% | -23.5% |
| 3 y3 years | +310.0% | -57.7% |
| 5 y5 years | +196.8% | -57.7% |
BRTX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -58.4% | at low | -57.7% | +1.6% |
| 5 y | 5-year | -58.4% | +164.3% | -57.7% | +148.6% |
| alltime | all time | -58.4% | +164.3% | -57.7% | +148.6% |
BioRestorative Therapies Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $8.93 M(-7.8%) |
| Jun 2024 | - | $9.68 M(-27.3%) |
| Mar 2024 | - | $13.32 M(+51.7%) |
| Dec 2023 | $8.78 M(-4.0%) | $8.78 M(-24.7%) |
| Sep 2023 | - | $11.67 M(+3.9%) |
| Jun 2023 | - | $11.23 M(-8.8%) |
| Mar 2023 | - | $12.31 M(+34.6%) |
| Dec 2022 | $9.15 M(-56.7%) | $9.15 M(-43.4%) |
| Sep 2022 | - | $16.17 M(-8.7%) |
| Jun 2022 | - | $17.70 M(-8.7%) |
| Mar 2022 | - | $19.39 M(-8.1%) |
| Dec 2021 | $21.10 M(+885.2%) | $21.10 M(+7024.9%) |
| Sep 2021 | - | $296.20 K(-41.1%) |
| Jun 2021 | - | $502.50 K(-61.4%) |
| Mar 2021 | - | $1.30 M(-39.2%) |
| Dec 2020 | $2.14 M(-115.7%) | $2.14 M(-284.7%) |
| Sep 2020 | - | -$1.16 M(+115.9%) |
| Jun 2020 | - | -$537.40 K(-97.1%) |
| Mar 2020 | - | -$18.36 M(+34.5%) |
| Dec 2019 | -$13.65 M(+50.5%) | -$13.65 M(+1.0%) |
| Sep 2019 | - | -$13.51 M(+38.1%) |
| Jun 2019 | - | -$9.79 M(+21.1%) |
| Mar 2019 | - | -$8.08 M(-10.9%) |
| Dec 2018 | -$9.07 M(+15.8%) | -$9.07 M(+3.8%) |
| Sep 2018 | - | -$8.74 M(-17.3%) |
| Jun 2018 | - | -$10.57 M(+20.4%) |
| Mar 2018 | - | -$8.78 M(+12.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | -$7.83 M(+35.7%) | -$7.83 M(-2.2%) |
| Sep 2017 | - | -$8.01 M(+15.3%) |
| Jun 2017 | - | -$6.95 M(+15.4%) |
| Mar 2017 | - | -$6.02 M(+4.3%) |
| Dec 2016 | -$5.77 M(+8.4%) | -$5.77 M(+4.6%) |
| Sep 2016 | - | -$5.52 M(+7.1%) |
| Jun 2016 | - | -$5.15 M(-1.0%) |
| Mar 2016 | - | -$5.21 M(-2.2%) |
| Dec 2015 | -$5.32 M(-36.7%) | -$5.32 M(+4.8%) |
| Sep 2015 | - | -$5.08 M(+8.7%) |
| Jun 2015 | - | -$4.67 M(-46.5%) |
| Mar 2015 | - | -$8.74 M(+3.9%) |
| Dec 2014 | -$8.41 M(+15.8%) | -$8.41 M(+20.0%) |
| Sep 2014 | - | -$7.01 M(-14.2%) |
| Jun 2014 | - | -$8.16 M(+4.8%) |
| Mar 2014 | - | -$7.79 M(+7.3%) |
| Dec 2013 | -$7.26 M(+160.8%) | -$7.26 M(-6.8%) |
| Sep 2013 | - | -$7.79 M(+137.0%) |
| Jun 2013 | - | -$3.29 M(+31.9%) |
| Mar 2013 | - | -$2.49 M(-10.5%) |
| Dec 2012 | -$2.78 M(-26.5%) | -$2.78 M(-56.1%) |
| Sep 2012 | - | -$6.35 M(+14.3%) |
| Jun 2012 | - | -$5.55 M(+26.1%) |
| Mar 2012 | - | -$4.40 M(+16.2%) |
| Dec 2011 | -$3.79 M(+279.7%) | -$3.79 M(+2.9%) |
| Sep 2011 | - | -$3.68 M(+269.1%) |
| Dec 2010 | -$997.80 K | -$997.80 K |
FAQ
- What is BioRestorative Therapies annual working capital?
- What is the all time high annual working capital for BioRestorative Therapies?
- What is BioRestorative Therapies annual working capital year-on-year change?
- What is BioRestorative Therapies quarterly working capital?
- What is the all time high quarterly working capital for BioRestorative Therapies?
- What is BioRestorative Therapies quarterly working capital year-on-year change?
What is BioRestorative Therapies annual working capital?
The current annual working capital of BRTX is $8.78 M
What is the all time high annual working capital for BioRestorative Therapies?
BioRestorative Therapies all-time high annual working capital is $21.10 M
What is BioRestorative Therapies annual working capital year-on-year change?
Over the past year, BRTX annual working capital has changed by -$363.30 K (-3.97%)
What is BioRestorative Therapies quarterly working capital?
The current quarterly working capital of BRTX is $8.93 M
What is the all time high quarterly working capital for BioRestorative Therapies?
BioRestorative Therapies all-time high quarterly working capital is $21.10 M
What is BioRestorative Therapies quarterly working capital year-on-year change?
Over the past year, BRTX quarterly working capital has changed by -$2.74 M (-23.51%)